Keywords: Ranbaxy, Daiichi Sankyo, Olmesartan, Africa,

Ranbaxy to launch Daiichi Sankyo’s olmesartan in six African markets

Article | 23 December 2009

Print This

Indian drug major Ranbaxy Laboratories, which is majority owned by Japan’s Daiichi Sankyo, is to launch olmesartan medoxomil, an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in